Skip to main content
Log in

Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis—initial results

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

This paper is a feasibility study of magnetic resonance imaging (MRI) of lung perfusion in children with cystic fibrosis (CF) using contrast-enhanced 3D MRI. Correlation assessment of perfusion changes with structural abnormalities. Eleven CF patients (9 f, 2 m; median age 16 years) were examined at 1.5 T. Morphology: HASTE coronal, transversal (TR/TE/α/ST: 600 ms/28 ms/180°/6 mm), breath-hold 18 s. Perfusion: Time-resolved 3D GRE pulse sequence (FLASH, TE/TR/α: 0.8/1.9 ms/40°), parallel imaging (GRAPPA, PAT 2). Twenty-five data sets were acquired after intravenous injection of 0.1 mmol/kg body weight of gadodiamide, 3–5 ml/s. A total of 198 lung segments were analyzed by two radiologists in consensus and scored for morphological and perfusion changes. Statistical analysis was performed by Mantel-Haenszel chi-square test. Results showed that perfusion defects were observed in all patients and present in 80% of upper, and 39% of lower lobes. Normal lung parenchyma showed homogeneous perfusion (86%, P<0.0001). Severe morphological changes led to perfusion defects (97%, P<0.0001). Segments with moderate morphological changes showed normal (53%) or impaired perfusion (47%). In conclusion, pulmonary perfusion is easy to judge in segments with normal parenchyma or severe changes. In moderately damaged segments, MRI of lung perfusion may help to better assess actual functional impairment. Contrast-enhanced 3D MRI of lung perfusion has the potential for early vascular functional assessment and therapy control in CF patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Davis PB, Drumm M, Konstan MW (1996) Cystic fibrosis. Am J Respir Crit Care Med 154(5):1229–1256

    PubMed  CAS  Google Scholar 

  2. Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168(8):918–951

    Article  PubMed  Google Scholar 

  3. Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326(18):1187–1191

    Article  PubMed  CAS  Google Scholar 

  4. v. Euler US, Liljestrand G (1947) Observations on the pulmonary arterial blood pressure in the cat. Acta Phys Scand 12:301–320

    Article  Google Scholar 

  5. Fazio F, Wollmer P (1981) Clinical ventilation-perfusion scintigraphy. Clin Physiol 1(4):323–337

    Article  PubMed  CAS  Google Scholar 

  6. Fauroux B, Itti E, Pigeot J, Isabey D, Meignan M, Ferry G, Lofaso F, Willemot JM, Clement A, Harf A (2000) Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. Am J Respir Crit Care Med 162(6):2265–2271

    PubMed  CAS  Google Scholar 

  7. Itti E, Fauroux B, Pigeot J, Isabey D, Clement A, Evangelista E, Harf A, Meignan M (2004) Quantitative lung perfusion scan as a predictor of aerosol distribution heterogeneity and disease severity in children with cystic fibrosis. Nucl Med Commun 25(6):563–569

    Article  PubMed  Google Scholar 

  8. Hatabu H, Gaa J, Kim D, Li W, Prasad PV, Edelman RR (1996) Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH. Magn Reson Med 36(4):503–508

    Article  PubMed  CAS  Google Scholar 

  9. Hatabu H, Tadamura E, Levin DL, Chen Q, Li W, Kim D, Prasad PV, Edelman RR (1999) Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI. Magn Reson Med 42(6):1033–1038

    Article  PubMed  CAS  Google Scholar 

  10. Uematsu H, Levin DL, Hatabu H (2001) Quantification of pulmonary perfusion with MR imaging: recent advances. Eur J Radiol 37(3):155–163

    Article  PubMed  CAS  Google Scholar 

  11. Fink C, Puderbach M, Bock M, Lodemann KP, Zuna I, Schmahl A, Delorme S, Kauczor HU (2004) Regional lung perfusion: assessment with partially parallel three-dimensional MR imaging. Radiology 231(1):175–184

    Article  PubMed  Google Scholar 

  12. Puderbach M, Eichinger M, Ley S, Fink C, Plathow C, Gahr J, Wiebel M, Tuengerthal S, Schmahl A, Mueller FM, Kauczor HU (2004) Visualisation of parenchymal lung changes in patients with cystic fibrosis (CF) - MRI versus HRCT. J Cyst Fibros 3(Suppl 1):54

    Google Scholar 

  13. Stern M, Sens B, Wiedermann B, Busse O, Damm G, Wenzlaff P (2005) Qualitätssicherung Mukoviszidose, Überblick über den Gesundheitszustand der Patienten in Deutschland 2004. Verlag Wissenschaftliche Scripten, Zwickau

    Google Scholar 

  14. Tiddens HA (2002) Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 34(3):228–231

    Article  PubMed  Google Scholar 

  15. Lindstrom M, Camner P, Falk R, Hjelte L, Philipson K, Svartengren M (2005) Long-term clearance from small airways in patients with cystic fibrosis. Eur Respir J 25(2):317–323

    Article  PubMed  CAS  Google Scholar 

  16. Barnes PJ (2004) Small airways in COPD. N Engl J Med 350(26):2635–2637

    Article  PubMed  CAS  Google Scholar 

  17. Fink C, Bock M, Puderbach M, Schmahl A, Delorme S (2003) Partially parallel three-dimensional magnetic resonance imaging for the assessment of lung perfusion-initial results. Invest Radiol 38(8):482–488

    Article  PubMed  Google Scholar 

  18. Ley S, Fink C, Puderbach M, Plathow C, Risse F, Kreitner KF, Kauczor HU (2004) Contrast-enhanced 3D MR perfusion of the lung: application of parallel imaging technique in healthy subjects. Rofo 176(3):330–334

    PubMed  CAS  Google Scholar 

  19. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW (2001) Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32(5):356–366

    Article  PubMed  CAS  Google Scholar 

  20. Fink C, Ley S, Risse F, Eichinger M, Zaporozhan J, Buhmann R, Puderbach M, Plathow C, Kauczor HU (2005) Effect of inspiratory and expiratory breathhold on pulmonary perfusion: assessment by pulmonary perfusion magnetic resonance imaging. Invest Radiol 40(2):72–79

    Article  PubMed  Google Scholar 

  21. Chrispin AR, Norman AP (1974) The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 2:101–106

    Article  PubMed  CAS  Google Scholar 

  22. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179(3):783–788

    PubMed  CAS  Google Scholar 

  23. Helbich TH, Heinz-Peer G, Eichler I, Wunderbaldinger P, Gotz M, Wojnarowski C, Brasch RC, Herold CJ (1999) Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 213(2):537–544

    PubMed  CAS  Google Scholar 

  24. Abolmaali N, Schmidt H, Anjorin A, Posselt H-G, Vogl TJ (2002) Chrispin-Norman-score and Bhalla-score of patients with cystic fibrosis: Comparative study of chest radiographs and MR-Imaging. Eur Radiol 12 [Congress Suppl]:227

  25. Vonk-Noordegraaf A, van Wolferen SA, Marcus JT, Boonstra A, Postmus PE, Peeters JW, Peacock AJ (2005) Noninvasive assessment and monitoring of the pulmonary circulation. Eur Respir J 25(4):758–766

    Article  PubMed  CAS  Google Scholar 

  26. Ley S, Puderbach M, Fink C, Eichinger M, Plathow C, Teiner S, Wiebel M, Muller FM, Kauczor HU (2005) Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI. Eur Radiol 15(8):1575–1580

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by Forschungsgemeinschaft Mukoviszidose (Mukoviszidose e.V.): S06/04.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monika Eichinger.

Additional information

Monika Eichinger and Michael Puderbach contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eichinger, M., Puderbach, M., Fink, C. et al. Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis—initial results. Eur Radiol 16, 2147–2152 (2006). https://doi.org/10.1007/s00330-006-0257-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-006-0257-7

Keywords

Navigation